The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Celebrating its centenary anniversary in 2012, American Imago was founded by Sigmund Freud and Hanns Sachsin the U.S.in 1939. The successor to Imago founded by Freud in Vienna in 1912, the journal retains its luster as the leading scholarly journal of psychoanalysis. Under the editorship of Louis Rose, each issue features cutting-edge articles that explore the enduring relevance of Freud's legacy across the humanities, arts, and social sciences.
American Jewish History is the official publication of the American Jewish Historical Society, the oldest national ethnic historical organization in the United States. The most widely recognized journal in its field, AJH focuses on every aspect ofthe American Jewish experience. Founded in 1892 as Publications of the American Jewish Historical Society, AJH has been the journal of record in American Jewish history for over a century, bringing readers all the richness and complexity of Jewish life in America through carefully researched, thoroughly accessible articles.
American journal of Agricultural and Biological Sciences is a peer reviewed broad multidisciplinary journal that publish research/ review articles relating to general biology and agriculture.
The American Journal of Alzheimer's Disease and Other Dementias® (AJADD) is for and by professionals on the frontlines of Alzheimer's care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, healthcare administrators, and other related healthcare specialists who deal with patients having dementias and families everyday. In every issue, you will find down-to-earth clinical information on * Practical medical, psychiatric, and nursing issues such as assessment and management of problem behaviors, communication difficulties, dealing with delusions and other psychotic features, apathy, effects of physical activity, integrated treatment approaches, new and changing pharmacotherapies, orientation behaviors, and hospice use. AJADD also includes information on management of concurrent medical issues in the patient with dementia. * New and forthcoming diagnostic tools such as computerized testing for mild cognitive impairment and other aspects of cognitive testing, as well as high technology resources for sophisticated disease characterization. AJADD also provides information on the clinical features and management of non-Alzheimer's dementias. * Psychosocial issues such as dealing with staff caregivers' distress, improving caregivers' communication skills, helping patients and families to deal with a diagnosis of Alzheimer's disease or another dementia, and patients' perceptions and preferences. * Practice-oriented clinical research from the frontiers of neurology and genetics, including sleep-wake states, targeting glutamate excitotoxicity, cholesterol and apolipoprotein E, and other aspects of the underlying biology that causes the symptoms of dementia. AJADD also reports on the latest clinical trials that focus on medications for the symptoms of dementia and the disease process. * Administrative and legal issues such as coding, consumer evaluation of adult day-care services, cost-effectiveness of special care units, dangerous wandering, end-stage dementia, informed consent, Medicare coverage for cognitively impaired residents, supervision of high-risk fall dementia patients, and vulnerable populations and avoidable hospitalizations.By 2025, it is estimated that there will be about 34 million people in the world with some form of Alzheimer's disease or other dementia. To stay ahead of the latest research, clinical practices and procedures, and administrative issues, subscribe to the American Journal of Alzheimer's Disease and Other Dementias® today!Read the American Journal of Alzheimer's Disease and Other Dementias® call for papers.